Download PDFPDF
039 Improved survival with abciximab if used during PCI for NSTEMI patients under 75 years of age
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address